ProfileGDS4718 / 203077_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 82% 89% 84% 84% 81% 81% 85% 80% 84% 85% 82% 88% 84% 86% 90% 88% 81% 89% 82% 86% 85% 85% 84% 87% 82% 81% 78% 80% 85% 80% 83% 80% 88% 85% 78% 77% 83% 82% 91% 83% 81% 86% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.3636984
GSM549102patient 115, normal, homogenized [OPG study]8.0073182
GSM549104patient 119, normal, homogenized [OPG study]9.0449689
GSM549108patient 138, normal, homogenized [OPG study]8.2246184
GSM549119patient 077, normal, homogenized [OPG study]8.2292284
GSM549133patient 032, cancer, homogenized [OPG study]8.131381
GSM549139patient 042, cancer, homogenized [OPG study]8.0477781
GSM549099patient 107, normal, homogenized [OPG study]8.4251585
GSM549109patient 139, normal, homogenized [OPG study]7.8290680
GSM549110patient 046, normal, homogenized [OPG study]8.3167984
GSM549114patient 063, normal, homogenized [OPG study]8.5521785
GSM549122patient 082, normal, homogenized [OPG study]8.1126782
GSM549134patient 033, cancer, homogenized [OPG study]8.9296288
GSM549136patient 036, cancer, homogenized [OPG study]8.4522984
GSM549140patient 044, cancer, homogenized [OPG study]8.6113186
GSM549111patient 047, normal, homogenized [OPG study]9.3602890
GSM549113patient 057, normal, homogenized [OPG study]9.0434888
GSM549132patient 031, cancer, homogenized [OPG study]7.9447881
GSM549137patient 038, cancer, homogenized [OPG study]8.9438689
GSM549142patient 047, cancer, homogenized [OPG study]7.7659582
GSM549100patient 110, normal, homogenized [OPG study]8.5191786
GSM549107patient 135, normal, homogenized [OPG study]8.5754285
GSM549115patient 068, normal, homogenized [OPG study]8.6601285
GSM549116patient 072, normal, homogenized [OPG study]8.4224884
GSM549120patient 078, normal, homogenized [OPG study]8.6972387
GSM549131patient 030, cancer, homogenized [OPG study]8.1715682
GSM549118patient 074, normal, homogenized [OPG study]7.9744681
GSM549129patient 027, cancer, homogenized [OPG study]7.7028378
GSM549123patient 088, normal, homogenized [OPG study]7.9105680
GSM549124patient 006, cancer, homogenized [OPG study]8.3347185
GSM549126patient 015, cancer, homogenized [OPG study]7.8724180
GSM549128patient 025, cancer, homogenized [OPG study]8.2754483
GSM549103patient 117, normal, homogenized [OPG study]7.6754180
GSM549117patient 073, normal, homogenized [OPG study]9.0502188
GSM549138patient 041, cancer, homogenized [OPG study]8.4381385
GSM549141patient 045, cancer, homogenized [OPG study]7.8122278
GSM549130patient 028, cancer, homogenized [OPG study]7.5455277
GSM549101patient 111, normal, homogenized [OPG study]8.1910583
GSM549105patient 128, normal, homogenized [OPG study]7.9941182
GSM549106patient 134, normal, homogenized [OPG study]9.4398591
GSM549112patient 048, normal, homogenized [OPG study]8.219483
GSM549125patient 011, cancer, homogenized [OPG study]7.9555281
GSM549127patient 024, cancer, homogenized [OPG study]8.5449186
GSM549135patient 035, cancer, homogenized [OPG study]4.6631534